Trastuzumab has anti-metastatic and anti-angiogenic activity in a spontaneous metastasis xenograft model of esophageal adenocarcinoma. Lange, Tobias Nentwich, Michael Lueth, Manuel Yekebas, Emre F. Schumacher, Udo 2011 - Forschungsinformationssystem des UKE
